This review highlights mechanisms of extracellular vesicles in liver disease and autoimmunity, suggesting potential therapies.
Bacterial extracellular vesicles (EVs) are increasingly recognized as pivotal mediators in host–microbe communication. Recent studies have elucidated that these nanoscale particles can cross the mucosal and blood barriers, disseminating bacterial components to distant organs such as the liver and joints. This review summarizes current research focusing on the mechanisms of EV translocation and their contributions to autoimmunity and cancer. Emphasis is placed on recent studies demonstrating EV-mediated systemic effects, particularly in liver disease and rheumatoid arthritis. Understanding these pathways may offer novel diagnostic and therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Claudia Günther (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: